BAYLAND CAPITAL
Bayland Capital is a leading investment firm with a focus on innovative life science companies globally.
BAYLAND CAPITAL
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-23 | CN Bio | Bayland Capital investment in Series B - CN Bio | 21 M USD |
| 2023-01-12 | LePure Biotech | Bayland Capital investment in Series C - LePure Biotech | N/A |
| 2022-08-26 | Lab Direct | Bayland Capital investment in Series A - Lab Direct | 10 M USD |
| 2021-11-05 | Wuxi Biortus Biosciences | Bayland Capital investment in Series B - Wuxi Biortus Biosciences | 200 M CNY |
| 2020-11-13 | Wuxi Biortus Biosciences | Bayland Capital investment in Series A - Wuxi Biortus Biosciences | 15 M USD |
More informations about "Bayland Capital"
Bayland Capital investment portfolio - PitchBook
Bayland Capital's latest investment was on 03-Mar-2025 in Danatlas Pharmaceutical, a company within the Drug Discovery industry. Data Transparency. Meet our data hygiene team. Discover …See details»
Biortus Gets $15 Mln From Pharmaron-Backed Bayland Capital
Nov 15, 2020 Wuxi Biortus Biosciences, a China contract research organization, recently obtained a $15 million investment led by Bayland Capital, Biortus said in a press release on …See details»
康君资本 | 投资机构信息-36氪
康君资本（Bayland Capital）是由康龙化成联合君联资本共同发起设立的生物医药领域专业投资机构，重点关注全球范围内的生物医药研发服务及技术创新平台。See details»
Bayland Capital - Investments, Portfolio & Company Exits
Apr 23, 2024 Bayland Capital has made 5 investments. Their most recent investment was on Apr 23, 2024 , when CN Bio raised $21M . How many investments has this organization made …See details»
Zicheng Zhao - Investment Manager - Bayland Capital 康君资本
- Bayland Capital is the corporate venture capital and strategy arm of Pharmaron, a publicly traded (HKG: 3759/SHE: 300759) global leading R&D service provider for the life sciences …See details»
Bayland Capital - CB Insights
Nov 3, 2021 The round was led by Novo Holdings, General Atlantic and Goldman Sachs Asset Management, with participation from existing investors including Highlight Capital, Bayland …See details»
CN Bio Innovations (t/a CN Bio) secures £17 million …
Apr 23, 2024 About Bayland Capital. Bayland Capital is the corporate venture capital arm of Pharmaron, a global life science contract research organization. Founded in 2019, Bayland Capital is led by a professional investment team …See details»
Trinomab introduces Bayland Capital, Huajin Avenue and other ...
With a unique industrial perspective, Bayland Capital Team makes use of its rich experience in industry, scientific research, management and capital market to invest globally, focusing on …See details»
Bayland Capital 康君资本 - LinkedIn
Partner at Bayland Capital, the Corporate Venture Platform of Pharmaron Yiren Dai 康龙化成(北京)新药技术股份有限公司 - 企业发展执行总监See details»
Bayland Capital Leads ~USD10m Series C for China’s SocialMed+ ...
Oct 7, 2022 GPCA is the global industry association for private capital in emerging markets. An independent, non-profit organization, the association brings together 300+ firms—including institutional investors, fund managers, and industry advisors—who manage more than USD2 trillion in assets across 130 countries. GPCA supports its members globally through …See details»
Bayland Capital - Investor Profile, Portfolio & Team - Tracxn
Jan 29, 2025 Bayland Capital - Venture capital firm focused on multiple sectors. Portfolio of 2 companies. 9 investors have invested with Bayland Capital.See details»
Bayland Capital - Updates, News, Events, Signals & Triggers
Bayland Capital is a leading investment firm with a focus on innovative life science companies globally.See details»
CN Bio raises $21 million USD in first close of Series B investment ...
Apr 23, 2024 Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively Investment will expand product development and scaling of the …See details»
Bayland Capital – Investors Database – Unicorn Nest
Bayland Capital. SAVE. Total investments. 5. Average round size. 15M. Portfolio companies. 4. Lead investments. 1. Follow on index. 0.20. Stages of investment Early Stage Venture ... At …See details»
Bayland Capital - VC Firm Profile - Gaebler.com Venture Capital …
Bayland Capital is a venture capital fund that backs technology-based companies. Venture Investor Overview. Venture Investor. Bayland Capital. Status. Active. Investor Type. Venture …See details»
BAYLAND CAPITAL MANAGEMENT, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BAYLAND CAPITAL MANAGEMENT, LLC of Houston, TX. Get the latest business insights from Dun & …See details»
Ground News - CN Bio raises $21 million USD in first close of …
Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10 M and $5.5 M, respectively. Investment will expand product development and scaling of the organization …See details»
CN Bio raises $21 million USD in first close of Series B investment …
Apr 23, 2024 Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10 M and $5.5 M, respectively. Investment will expand product development and scaling of …See details»
BAYLAND CAPITAL MANAGEMENT, LLC
May 16, 2011 Bayland Capital Management, LLC 729 Bayland Avenue, Houston, TX 77009 Telephone Number: (657) 229-2270 Email: [email protected] THE COMMODITY …See details»
CN Bio raises $21m in first close of Series B investment round
Bayland Capital is the corporate venture capital arm of Pharmaron, a global life science contract research organisation. Founded in 2019, Bayland Capital is led by a professional investment …See details»